SP-MHCI-0477-3

Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

US$507.00

In stock

Description

About Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

The Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein Peptide (IEDB: 38467) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-LPFDKSTIM-OH (Uniprot: P03466 aa: 418-426) from JPT is produced under strict quality control and quality management.

Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM - Specifications

  • Peptide sequence: H-LPFDKSTIM-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Influenza
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM has been described in:
Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes., J Virol, 2002 (PMID: 11836437)
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope., J Virol, 2009 (PMID: 19553306)
Two preferentially expressed proteins protect vascular endothelial cells from an attack by peptide-specific CTL., J Immunol, 2012 (PMID: 22544926)

Documentation

Documentation for Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

Properties

Properties of Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Influenza
Layout: Freeze-dried in glass vial
Organism: Influenza A
Protein Name: Nucleoprotein
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Influenza A (strain A/Puerto Rico/8/1934 H1N1) Nucleoprotein 418-426, LPFDKSTIM

Information Values
Sequence: H-LPFDKSTIM-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote